1h Free Analyst Time
Speak directly to the analyst to clarify any post sales queries you may have.
The human ciliary neurotrophic factor (CNTF) market is evolving rapidly, driven by scientific breakthroughs, regulatory changes, and increased bioprocessing capabilities. As innovation reshapes therapeutic, diagnostic, and research landscapes, senior decision-makers face a dynamic ecosystem demanding strategic agility and forward-thinking investment.
Market Snapshot
The global human CNTF market is experiencing significant growth as its applications expand across diagnostics, therapeutics, and advanced research. Advanced recombinant expression and new delivery methods are streamlining production while multifaceted collaboration between biotechnology firms, academic institutions, and contract manufacturers continue to accelerate innovation cycles. Regulatory authorities are updating frameworks to facilitate the development and commercialization of novel biologic products, signaling fresh opportunities and operational considerations for key industry stakeholders.
Scope & Segmentation
This report provides a detailed analysis of the human CNTF market across multiple dimensions, covering product development, applications, and manufacturing methods. The following are the principal segments and regional coverage included:
- Applications: Diagnostics, Research and Development, Therapeutic (including Neurology such as amyotrophic lateral sclerosis and traumatic brain injury, and Ophthalmology, covering optic neuropathies and retinal disorders)
- Product Types: Natural, Recombinant
- Protein Expression Systems: Cell-Free, E. coli, Mammalian, Yeast
- Administration Routes: Intracerebral, Intravenous, Intravitreal, Subretinal
- End Users: Diagnostic Laboratories, Hospitals and Clinics, Pharmaceutical Companies, Research Institutes
- Purity Grades: Analytical Grade, Bioprocess Grade, Clinical Grade
- Regions: Americas (including United States, Canada, Brazil, Mexico, Argentina), Europe, Middle East & Africa (United Kingdom, Germany, France, and others), Asia-Pacific (China, India, Japan, Australia, and additional key markets)
Key Takeaways
- Emerging scientific advances, such as proteomic profiling and single-cell analytics, are revealing novel CNTF receptor isoforms and supporting targeted therapies with optimal selectivity.
- Refined localized delivery techniques, including intravitreal and subretinal administration, are mitigating systemic exposure and enabling precision dosing in neurology and ophthalmology applications.
- Collaborative research approaches involving public-private consortia and cross-sector alliances facilitate large-scale clinical trials, supporting translation from foundational discoveries to actionable therapies.
- Quality by design frameworks and evolving regulatory guidance underpin the market's move towards consistent purity standards and scalable manufacturing, enhancing compliance and sustainability.
- Industry leaders are adapting their sourcing and manufacturing strategies to accommodate regional supply chain pressures, while leveraging technological innovation to reduce process bottlenecks.
Tariff Impact: 2025 U.S. Policy Shifts
The 2025 United States tariff measures have initiated a strategic pivot within the human CNTF supply chain. Increased duties on biopharmaceutical imports are prompting manufacturers to recalibrate sourcing strategies, resulting in greater domestic production and expansion of regional partnerships. Investments in process optimization, such as cell-free synthesis and enhanced microbial expression, are enabling stakeholders to control costs and bolster resilience. Multi-institutional cost-sharing models are emerging to support research continuity and mitigate capital outlays tied to in-house manufacturing expansion.
Methodology & Data Sources
Insights in this report are grounded in primary interviews with academic and biopharmaceutical leaders, supplemented by a comprehensive review of peer-reviewed literature, patent filings, whitepapers, and regulatory documents. Quantitative findings are verified through triangulated data from supplier catalogs and clinical trial records. Subject matter experts have peer reviewed all recommendations and conclusions.
Why This Report Matters
- Delivers actionable recommendations for capturing growth opportunities in diagnostics, therapeutics, and collaborative R&D within the human ciliary neurotrophic factor field.
- Helps inform supply chain pivot strategies in light of evolving tariff environments and regional manufacturing dynamics.
- Equips commercial leaders with segmentation insights and regional intelligence to guide partnerships and long-term investment.
Conclusion
Human CNTF market prospects are defined by innovation in production methods, adaptive regulatory alignment, and region-specific growth levers. Strategic agility and informed investment decisions will be crucial for stakeholders aiming to capitalize on near-term and future opportunities.
This product will be delivered within 1-3 business days.
Table of Contents
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Advances in CNTF protein engineering for enhanced neuroprotective efficacy in optic neuropathies and amyotrophic lateral sclerosis
5.2. Growth in personalized medicine approaches using CNTF-based therapies for retinal degeneration driven by genetic biomarkers
5.3. Rising strategic partnerships between biotech firms and academic institutions to accelerate CNTF clinical pipeline for neurodegenerative diseases
5.4. Increasing investment in sustained-release formulations of CNTF for chronic ophthalmic conditions to improve patient adherence
5.5. Regulatory advancements and FDA fast-track designations for CNTF analogs targeting rare neurological disorders to streamline approval pathways
5.2. Growth in personalized medicine approaches using CNTF-based therapies for retinal degeneration driven by genetic biomarkers
5.3. Rising strategic partnerships between biotech firms and academic institutions to accelerate CNTF clinical pipeline for neurodegenerative diseases
5.4. Increasing investment in sustained-release formulations of CNTF for chronic ophthalmic conditions to improve patient adherence
5.5. Regulatory advancements and FDA fast-track designations for CNTF analogs targeting rare neurological disorders to streamline approval pathways
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
6.2. PESTLE Analysis
8. Human Ciliary Neurotrophic Factor Market, by Application
8.1. Introduction
8.2. Diagnostics
8.3. Research And Development
8.4. Therapeutic
8.4.1. Neurology
8.4.1.1. Amyotrophic Lateral Sclerosis
8.4.1.2. Traumatic Brain Injury
8.4.2. Ophthalmology
8.4.2.1. Optic Neuropathies
8.4.2.2. Retinal Disorders
8.2. Diagnostics
8.3. Research And Development
8.4. Therapeutic
8.4.1. Neurology
8.4.1.1. Amyotrophic Lateral Sclerosis
8.4.1.2. Traumatic Brain Injury
8.4.2. Ophthalmology
8.4.2.1. Optic Neuropathies
8.4.2.2. Retinal Disorders
9. Human Ciliary Neurotrophic Factor Market, by Product Type
9.1. Introduction
9.2. Natural
9.3. Recombinant
9.2. Natural
9.3. Recombinant
10. Human Ciliary Neurotrophic Factor Market, by Protein Expression System
10.1. Introduction
10.2. Cell-Free
10.3. Ecoli
10.4. Mammalian
10.5. Yeast
10.2. Cell-Free
10.3. Ecoli
10.4. Mammalian
10.5. Yeast
11. Human Ciliary Neurotrophic Factor Market, by Administration Route
11.1. Introduction
11.2. Intracerebral
11.3. Intravenous
11.4. Intravitreal
11.5. Subretinal
11.2. Intracerebral
11.3. Intravenous
11.4. Intravitreal
11.5. Subretinal
12. Human Ciliary Neurotrophic Factor Market, by End User
12.1. Introduction
12.2. Diagnostic Laboratories
12.3. Hospitals And Clinics
12.4. Pharmaceutical Companies
12.5. Research Institutes
12.2. Diagnostic Laboratories
12.3. Hospitals And Clinics
12.4. Pharmaceutical Companies
12.5. Research Institutes
13. Human Ciliary Neurotrophic Factor Market, by Purity Grade
13.1. Introduction
13.2. Analytical Grade
13.3. Bioprocess Grade
13.4. Clinical Grade
13.2. Analytical Grade
13.3. Bioprocess Grade
13.4. Clinical Grade
14. Americas Human Ciliary Neurotrophic Factor Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Human Ciliary Neurotrophic Factor Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Human Ciliary Neurotrophic Factor Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Thermo Fisher Scientific Inc.
17.3.2. Merck KGaA
17.3.3. Bio-Techne Corporation
17.3.4. Abcam plc
17.3.5. Sino Biological Inc.
17.3.6. GenScript Biotech Corporation
17.3.7. RayBiotech, Inc.
17.3.8. Proteintech Group, Inc.
17.3.9. Creative Biolabs, Inc.
17.3.10. Novus Biologicals LLC
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Thermo Fisher Scientific Inc.
17.3.2. Merck KGaA
17.3.3. Bio-Techne Corporation
17.3.4. Abcam plc
17.3.5. Sino Biological Inc.
17.3.6. GenScript Biotech Corporation
17.3.7. RayBiotech, Inc.
17.3.8. Proteintech Group, Inc.
17.3.9. Creative Biolabs, Inc.
17.3.10. Novus Biologicals LLC
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. HUMAN CILIARY NEUROTROPHIC FACTOR MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 6. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PROTEIN EXPRESSION SYSTEM, 2024 VS 2030 (%)
FIGURE 10. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PROTEIN EXPRESSION SYSTEM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY ADMINISTRATION ROUTE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY ADMINISTRATION ROUTE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PURITY GRADE, 2024 VS 2030 (%)
FIGURE 16. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PURITY GRADE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. HUMAN CILIARY NEUROTROPHIC FACTOR MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. HUMAN CILIARY NEUROTROPHIC FACTOR MARKET: RESEARCHAI
FIGURE 28. HUMAN CILIARY NEUROTROPHIC FACTOR MARKET: RESEARCHSTATISTICS
FIGURE 29. HUMAN CILIARY NEUROTROPHIC FACTOR MARKET: RESEARCHCONTACTS
FIGURE 30. HUMAN CILIARY NEUROTROPHIC FACTOR MARKET: RESEARCHARTICLES
FIGURE 2. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 6. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PROTEIN EXPRESSION SYSTEM, 2024 VS 2030 (%)
FIGURE 10. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PROTEIN EXPRESSION SYSTEM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY ADMINISTRATION ROUTE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY ADMINISTRATION ROUTE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PURITY GRADE, 2024 VS 2030 (%)
FIGURE 16. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PURITY GRADE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. HUMAN CILIARY NEUROTROPHIC FACTOR MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. HUMAN CILIARY NEUROTROPHIC FACTOR MARKET: RESEARCHAI
FIGURE 28. HUMAN CILIARY NEUROTROPHIC FACTOR MARKET: RESEARCHSTATISTICS
FIGURE 29. HUMAN CILIARY NEUROTROPHIC FACTOR MARKET: RESEARCHCONTACTS
FIGURE 30. HUMAN CILIARY NEUROTROPHIC FACTOR MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY RESEARCH AND DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY RESEARCH AND DEVELOPMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY THERAPEUTIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY THERAPEUTIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY NEUROLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY AMYOTROPHIC LATERAL SCLEROSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY AMYOTROPHIC LATERAL SCLEROSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY TRAUMATIC BRAIN INJURY, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY TRAUMATIC BRAIN INJURY, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY OPHTHALMOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY OPHTHALMOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY OPTIC NEUROPATHIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY OPTIC NEUROPATHIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY RETINAL DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY RETINAL DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY OPHTHALMOLOGY, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY OPHTHALMOLOGY, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY THERAPEUTIC, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY THERAPEUTIC, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY NATURAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY NATURAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY RECOMBINANT, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY RECOMBINANT, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PROTEIN EXPRESSION SYSTEM, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PROTEIN EXPRESSION SYSTEM, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY CELL-FREE, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY CELL-FREE, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY ECOLI, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY ECOLI, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY MAMMALIAN, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY MAMMALIAN, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY YEAST, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY YEAST, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY INTRACEREBRAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY INTRACEREBRAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY INTRAVENOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY INTRAVITREAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY INTRAVITREAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY SUBRETINAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY SUBRETINAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PURITY GRADE, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PURITY GRADE, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY ANALYTICAL GRADE, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY ANALYTICAL GRADE, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY BIOPROCESS GRADE, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY BIOPROCESS GRADE, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY CLINICAL GRADE, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY CLINICAL GRADE, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY THERAPEUTIC, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY THERAPEUTIC, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY OPHTHALMOLOGY, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY OPHTHALMOLOGY, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PROTEIN EXPRESSION SYSTEM, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PROTEIN EXPRESSION SYSTEM, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PURITY GRADE, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PURITY GRADE, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 99. UNITED STATES HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 100. UNITED STATES HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 101. UNITED STATES HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY THERAPEUTIC, 2018-2024 (USD MILLION)
TABLE 102. UNITED STATES HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY THERAPEUTIC, 2025-2030 (USD MILLION)
TABLE 103. UNITED STATES HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
TABLE 104. UNITED STATES HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
TABLE 105. UNITED STATES HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY OPHTHALMOLOGY, 2018-2024 (USD MILLION)
TABLE 106. UNITED STATES HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY OPHTHALMOLOGY, 2025-2030 (USD MILLION)
TABLE 107. UNITED STATES HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 108. UNITED STATES HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 109. UNITED STATES HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PROTEIN EXPRESSION SYSTEM, 2018-2024 (USD MILLION)
TABLE 110. UNITED STATES HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PROTEIN EXPRESSION SYSTEM, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 113. UNITED STATES HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 114. UNITED STATES HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PURITY GRADE, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PURITY GRADE, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 119. CANADA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 120. CANADA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 121. CANADA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY THERAPEUTIC, 2018-2024 (USD MILLION)
TABLE 122. CANADA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY THERAPEUTIC, 2025-2030 (USD MILLION)
TABLE 123. CANADA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
TABLE 124. CANADA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
TABLE 125. CANADA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY OPHTHALMOLOGY, 2018-2024 (USD MILLION)
TABLE 126. CANADA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY OPHTHALMOLOGY, 2025-2030 (USD MILLION)
TABLE 127. CANADA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 128. CANADA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 129. CANADA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PROTEIN EXPRESSION SYSTEM, 2018-2024 (USD MILLION)
TABLE 130. CANADA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PROTEIN EXPRESSION SYSTEM, 2025-2030 (USD MILLION)
TABLE 131. CANADA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 132. CANADA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 133. CANADA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 134. CANADA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 135. CANADA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PURITY GRADE, 2018-2024 (USD MILLION)
TABLE 136. CANADA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PURITY GRADE, 2025-2030 (USD MILLION)
TABLE 137. MEXICO HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 138. MEXICO HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 139. MEXICO HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY THERAPEUTIC, 2018-2024 (USD MILLION)
TABLE 140. MEXICO HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY THERAPEUTIC, 2025-2030 (USD MILLION)
TABLE 141. MEXICO HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
TABLE 142. MEXICO HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
TABLE 143. MEXICO HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY OPHTHALMOLOGY, 2018-2024 (USD MILLION)
TABLE 144. MEXICO HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY OPHTHALMOLOGY, 2025-2030 (USD MILLION)
TABLE 145. MEXICO HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 146. MEXICO HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 147. MEXICO HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PROTEIN EXPRESSION SYSTEM, 2018-2024 (USD MILLION)
TABLE 148. MEXICO HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PROTEIN EXPRESSION SYSTEM, 2025-2030 (USD MILLION)
TABLE 149. MEXICO HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 150. MEXICO HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 151. MEXICO HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 152. MEXICO HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 153. MEXICO HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PURITY GRADE, 2018-2024 (USD MILLION)
TABLE 154. MEXICO HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PURITY GRADE, 2025-2030 (USD MILLION)
TABLE 155. BRAZIL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 156. BRAZIL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 157. BRAZIL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY THERAPEUTIC, 2018-2024 (USD MILLION)
TABLE 158. BRAZIL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY THERAPEUTIC, 2025-2030 (USD MILLION)
TABLE 159. BRAZIL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
TABLE 160. BRAZIL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
TABLE 161. BRAZIL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY OPHTHALMOLOGY, 2018-2024 (USD MILLION)
TABLE 162. BRAZIL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY OPHTHALMOLOGY, 2025-2030 (USD MILLION)
TABLE 163. BRAZIL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 164. BRAZIL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 165. BRAZIL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PROTEIN EXPRESSION SYSTEM, 2018-2024 (USD MILLION)
TABLE 166. BRAZIL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PROTEIN EXPRESSION SYSTEM, 2025-2030 (USD MILLION)
TABLE 167. BRAZIL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 168. BRAZIL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 169. BRAZIL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 170. BRAZIL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 171. BRAZIL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PURITY GRADE, 2018-2024 (USD MILLION)
TABLE 172. BRAZIL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PURITY GRADE, 2025-2030 (USD MILLION)
TABLE 173. ARGENTINA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 174. ARGENTINA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 175. ARGENTINA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY THERAPEUTIC, 2018-2024 (USD MILLION)
TABLE 176. ARGENTINA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY THERAPEUTIC, 2025-2030 (USD MILLION)
TABLE 177. ARGENTINA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
TABLE 178. ARGENTINA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
TABLE 179. ARGENTINA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY OPHTHALMOLOGY, 2018-2024 (USD MILLION)
TABLE 180. ARGENTINA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY OPHTHALMOLOGY, 2025-2030 (USD MILLION)
TABLE 181. ARGENTINA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 182. ARGENTINA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 183. ARGENTINA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PROTEIN EXPRESSION SYSTEM, 2018-2024 (USD MILLION)
TABLE 184. ARGENTINA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PROTEIN EXPRESSION SYSTEM, 2025-2030 (USD MILLION)
TABLE 185. ARGENTINA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 186. ARGENTINA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 187. ARGENTINA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 188. ARGENTINA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 189. ARGENTINA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PURITY GRADE, 2018-2024 (USD MILLION)
TABLE 190. ARGENTINA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PURITY GRADE, 2025-2030 (USD MILLION)
TABLE 191. EUROPE, MIDDLE EAST & AFRICA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 192. EUROPE, MIDDLE EAST & AFRICA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 193. EUROPE, MIDDLE EAST & AFRICA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY THERAPEUTIC, 2018-2024 (USD MILLION)
TABLE 194. EUROPE, MIDDLE EAST & AFRICA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY THERAPEUTIC, 2025-2030 (USD MILLION)
TABLE 195. EUROPE, MIDDLE EAST & AFRICA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
TABLE 196. EUROPE, MIDDLE EAST & AFRICA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
TABLE 197. EUROPE, MIDDLE EAST & AFRICA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY OPHTHALMOLOGY, 2018-2024 (USD MILLION)
TABLE 198. EUROPE, MIDDLE EAST & AFRICA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY OPHTHALMOLOGY, 2025-2030 (USD MILLION)
TABLE 199. EUROPE, MIDDLE EAST & AFRICA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 200. EUROPE, MIDDLE EAST & AFRICA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 201. EUROPE, MIDDLE EAST & AFRICA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PROTEIN EXPRESSION SYSTEM, 2018-2024 (USD MILLION)
TABLE 202. EUROPE, MIDDLE EAST & AFRICA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PROTEIN EXPRESSION SYSTEM, 2025-2030 (USD MILLION)
TABLE 203. EUROPE, MIDDLE EAST & AFRICA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 204. EUROPE, MIDDLE EAST & AFRICA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 205. EUROPE, MIDDLE EAST & AFRICA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 206. EUROPE, MIDDLE EAST & AFRICA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 207. EUROPE, MIDDLE EAST & AFRICA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PURITY GRADE, 2018-2024 (USD MILLION)
TABLE 208. EUROPE, MIDDLE EAST & AFRICA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PURITY GRADE, 2025-2030 (USD MILLION)
TABLE 209. EUROPE, MIDDLE EAST & AFRICA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 210. EUROPE, MIDDLE EAST & AFRICA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 211. UNITED KINGDOM HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 212. UNITED KINGDOM HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 213. UNITED KINGDOM HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY THERAPEUTIC, 2018-2024 (USD MILLION)
TABLE 214. UNITED KINGDOM HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY THERAPEUTIC, 2025-2030 (USD MILLION)
TABLE 215. UNITED KINGDOM HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
TABLE 216. UNITED KINGDOM HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
TABLE 217. UNITED KINGDOM HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY OPHTHALMOLOGY, 2018-2024 (USD MILLION)
TABLE 218. UNITED KINGDOM HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY OPHTHALMOLOGY, 2025-2030 (USD MILLION)
TABLE 219. UNITED KINGDOM HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 220. UNITED KINGDOM HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 221. UNITED KINGDOM HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PROTEIN EXPRESSION SYSTEM, 2018-2024 (USD MILLION)
TABLE 222. UNITED KINGDOM HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PROTEIN EXPRESSION SYSTEM, 2025-2030 (USD MILLION)
TABLE 223. UNITED KINGDOM HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 224. UNITED KINGDOM HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 225. UNITED KINGDOM HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 226. UNITED KINGDOM HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 227. UNITED KINGDOM HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PURITY GRADE, 2018-2024 (USD MILLION)
TABLE 228. UNITED KINGDOM HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PURITY GRADE, 2025-2030 (USD MILLION)
TABLE 229. GERMANY HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 230. GERMANY HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 231. GERMANY HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY THERAPEUTIC, 2018-2024 (USD MILLION)
TABLE 232. GERMANY HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY THERAPEUTIC, 2025-2030 (USD MILLION)
TABLE 233. GERMANY HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
TABLE 234. GERMANY HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
TABLE 235. GERMANY HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY OPHTHALMOLOGY, 2018-2024 (USD MILLION)
TABLE 236. GERMANY HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY OPHTHALMOLOGY, 2025-2030 (USD MILLION)
TABLE 237. GERMANY HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 238. GERMANY HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 239. GERMANY HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PROTEIN EXPRESSION SYSTEM, 2018-2024 (USD MILLION)
TABLE 240. GERMANY HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PROTEIN EXPRESSION SYSTEM, 2025-2030 (USD MILLION)
TABLE 241. GERMANY HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 242. GERMANY HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 243. GERMANY HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 244. GERMANY HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 245. GERMANY HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PURITY GRADE, 2018-2024 (USD MILLION)
TABLE 246. GERMANY HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PURITY GRADE, 2025-2030 (USD MILLION)
TABLE 247. FRANCE HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 248. FRANCE HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 249. FRANCE HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY THERAPEUTIC, 2018-2024 (USD MILLION)
TABLE 250. FRANCE HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY THERAPEUTIC, 2025-2030 (USD MILLION)
TABLE 251. FRANCE HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
TABLE 252. FRANCE HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
TABLE 253. FRANCE HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY OPHTHALMOLOGY, 2018-2024 (USD MILLION)
TABLE 254. FRANCE HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY OPHTHALMOLOGY, 2025-2030 (USD MILLION)
TABLE 255. FRANCE HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 256. FRANCE HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 257. FRANCE HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PROTEIN EXPRESSION SYSTEM, 2018-2024 (USD MILLION)
TABLE 258. FRANCE HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PROTEIN EXPRESSION SYSTEM, 2025-2030 (USD MILLION)
TABLE 259. FRANCE HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 260. FRANCE HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 261. FRANCE HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 262. FRANCE HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 263. FRANCE HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PURITY GRADE, 2018-2024 (USD MILLION)
TABLE 264. FRANCE HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PURITY GRADE, 2025-2030 (USD MILLION)
TABLE 265. RUSSIA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 266. RUSSIA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 267. RUSSIA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY THERAPEUTIC, 2018-2024 (USD MILLION)
TABLE 268. RUSSIA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY THERAPEUTIC, 2025-2030 (USD MILLION)
TABLE 269. RUSSIA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
TABLE 270. RUSSIA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
TABLE 271. RUSSIA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY OPHTHALMOLOGY, 2018-2024 (USD MILLION)
TABLE 272. RUSSIA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY OPHTHALMOLOGY, 2025-2030 (USD MILLION)
TABLE 273. RUSSIA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 274. RUSSIA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 275. RUSSIA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PROTEIN EXPRESSION SYSTEM, 2018-2024 (USD MILLION)
TABLE 276. RUSSIA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PROTEIN EXPRESSION SYSTEM, 2025-2030 (USD MILLION)
TABLE 277. RUSSIA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 278. RUSSIA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 279. RUSSIA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 280. RUSSIA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 281. RUSSIA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PURITY GRADE, 2018-2024 (USD MILLION)
TABLE 282. RUSSIA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PURITY GRADE, 2025-2030 (USD MILLION)
TABLE 283. ITALY HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 284. ITALY HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 285. ITALY HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY THERAPEUTIC, 2018-2024 (USD MILLION)
TABLE 286. ITALY HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY THERAPEUTIC, 2025-2030 (USD MILLION)
TABLE 287. ITALY HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
TABLE 288. ITALY HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
TABLE 289. ITALY HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY OPHTHALMOLOGY, 2018-2024 (USD MILLION)
TABLE 290. ITALY HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY OPHTHALMOLOGY, 2025-2030 (USD MILLION)
TABLE 291. ITALY HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 292. ITALY HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 293. ITALY HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PROTEIN EXPRESSION SYSTEM, 2018-2024 (USD MILLION)
TABLE 294. ITALY HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PROTEIN EXPRESSION SYSTEM, 2025-2030 (USD MILLION)
TABLE 295. ITALY H
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY RESEARCH AND DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY RESEARCH AND DEVELOPMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY THERAPEUTIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY THERAPEUTIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY NEUROLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY AMYOTROPHIC LATERAL SCLEROSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY AMYOTROPHIC LATERAL SCLEROSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY TRAUMATIC BRAIN INJURY, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY TRAUMATIC BRAIN INJURY, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY OPHTHALMOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY OPHTHALMOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY OPTIC NEUROPATHIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY OPTIC NEUROPATHIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY RETINAL DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY RETINAL DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY OPHTHALMOLOGY, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY OPHTHALMOLOGY, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY THERAPEUTIC, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY THERAPEUTIC, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY NATURAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY NATURAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY RECOMBINANT, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY RECOMBINANT, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PROTEIN EXPRESSION SYSTEM, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PROTEIN EXPRESSION SYSTEM, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY CELL-FREE, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY CELL-FREE, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY ECOLI, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY ECOLI, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY MAMMALIAN, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY MAMMALIAN, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY YEAST, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY YEAST, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY INTRACEREBRAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY INTRACEREBRAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY INTRAVENOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY INTRAVITREAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY INTRAVITREAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY SUBRETINAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY SUBRETINAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PURITY GRADE, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PURITY GRADE, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY ANALYTICAL GRADE, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY ANALYTICAL GRADE, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY BIOPROCESS GRADE, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY BIOPROCESS GRADE, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY CLINICAL GRADE, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY CLINICAL GRADE, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY THERAPEUTIC, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY THERAPEUTIC, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY OPHTHALMOLOGY, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY OPHTHALMOLOGY, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PROTEIN EXPRESSION SYSTEM, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PROTEIN EXPRESSION SYSTEM, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PURITY GRADE, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PURITY GRADE, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 99. UNITED STATES HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 100. UNITED STATES HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 101. UNITED STATES HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY THERAPEUTIC, 2018-2024 (USD MILLION)
TABLE 102. UNITED STATES HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY THERAPEUTIC, 2025-2030 (USD MILLION)
TABLE 103. UNITED STATES HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
TABLE 104. UNITED STATES HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
TABLE 105. UNITED STATES HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY OPHTHALMOLOGY, 2018-2024 (USD MILLION)
TABLE 106. UNITED STATES HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY OPHTHALMOLOGY, 2025-2030 (USD MILLION)
TABLE 107. UNITED STATES HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 108. UNITED STATES HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 109. UNITED STATES HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PROTEIN EXPRESSION SYSTEM, 2018-2024 (USD MILLION)
TABLE 110. UNITED STATES HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PROTEIN EXPRESSION SYSTEM, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 113. UNITED STATES HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 114. UNITED STATES HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PURITY GRADE, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PURITY GRADE, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 119. CANADA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 120. CANADA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 121. CANADA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY THERAPEUTIC, 2018-2024 (USD MILLION)
TABLE 122. CANADA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY THERAPEUTIC, 2025-2030 (USD MILLION)
TABLE 123. CANADA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
TABLE 124. CANADA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
TABLE 125. CANADA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY OPHTHALMOLOGY, 2018-2024 (USD MILLION)
TABLE 126. CANADA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY OPHTHALMOLOGY, 2025-2030 (USD MILLION)
TABLE 127. CANADA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 128. CANADA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 129. CANADA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PROTEIN EXPRESSION SYSTEM, 2018-2024 (USD MILLION)
TABLE 130. CANADA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PROTEIN EXPRESSION SYSTEM, 2025-2030 (USD MILLION)
TABLE 131. CANADA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 132. CANADA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 133. CANADA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 134. CANADA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 135. CANADA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PURITY GRADE, 2018-2024 (USD MILLION)
TABLE 136. CANADA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PURITY GRADE, 2025-2030 (USD MILLION)
TABLE 137. MEXICO HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 138. MEXICO HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 139. MEXICO HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY THERAPEUTIC, 2018-2024 (USD MILLION)
TABLE 140. MEXICO HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY THERAPEUTIC, 2025-2030 (USD MILLION)
TABLE 141. MEXICO HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
TABLE 142. MEXICO HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
TABLE 143. MEXICO HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY OPHTHALMOLOGY, 2018-2024 (USD MILLION)
TABLE 144. MEXICO HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY OPHTHALMOLOGY, 2025-2030 (USD MILLION)
TABLE 145. MEXICO HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 146. MEXICO HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 147. MEXICO HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PROTEIN EXPRESSION SYSTEM, 2018-2024 (USD MILLION)
TABLE 148. MEXICO HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PROTEIN EXPRESSION SYSTEM, 2025-2030 (USD MILLION)
TABLE 149. MEXICO HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 150. MEXICO HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 151. MEXICO HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 152. MEXICO HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 153. MEXICO HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PURITY GRADE, 2018-2024 (USD MILLION)
TABLE 154. MEXICO HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PURITY GRADE, 2025-2030 (USD MILLION)
TABLE 155. BRAZIL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 156. BRAZIL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 157. BRAZIL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY THERAPEUTIC, 2018-2024 (USD MILLION)
TABLE 158. BRAZIL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY THERAPEUTIC, 2025-2030 (USD MILLION)
TABLE 159. BRAZIL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
TABLE 160. BRAZIL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
TABLE 161. BRAZIL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY OPHTHALMOLOGY, 2018-2024 (USD MILLION)
TABLE 162. BRAZIL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY OPHTHALMOLOGY, 2025-2030 (USD MILLION)
TABLE 163. BRAZIL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 164. BRAZIL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 165. BRAZIL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PROTEIN EXPRESSION SYSTEM, 2018-2024 (USD MILLION)
TABLE 166. BRAZIL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PROTEIN EXPRESSION SYSTEM, 2025-2030 (USD MILLION)
TABLE 167. BRAZIL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 168. BRAZIL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 169. BRAZIL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 170. BRAZIL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 171. BRAZIL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PURITY GRADE, 2018-2024 (USD MILLION)
TABLE 172. BRAZIL HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PURITY GRADE, 2025-2030 (USD MILLION)
TABLE 173. ARGENTINA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 174. ARGENTINA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 175. ARGENTINA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY THERAPEUTIC, 2018-2024 (USD MILLION)
TABLE 176. ARGENTINA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY THERAPEUTIC, 2025-2030 (USD MILLION)
TABLE 177. ARGENTINA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
TABLE 178. ARGENTINA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
TABLE 179. ARGENTINA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY OPHTHALMOLOGY, 2018-2024 (USD MILLION)
TABLE 180. ARGENTINA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY OPHTHALMOLOGY, 2025-2030 (USD MILLION)
TABLE 181. ARGENTINA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 182. ARGENTINA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 183. ARGENTINA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PROTEIN EXPRESSION SYSTEM, 2018-2024 (USD MILLION)
TABLE 184. ARGENTINA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PROTEIN EXPRESSION SYSTEM, 2025-2030 (USD MILLION)
TABLE 185. ARGENTINA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 186. ARGENTINA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 187. ARGENTINA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 188. ARGENTINA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 189. ARGENTINA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PURITY GRADE, 2018-2024 (USD MILLION)
TABLE 190. ARGENTINA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PURITY GRADE, 2025-2030 (USD MILLION)
TABLE 191. EUROPE, MIDDLE EAST & AFRICA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 192. EUROPE, MIDDLE EAST & AFRICA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 193. EUROPE, MIDDLE EAST & AFRICA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY THERAPEUTIC, 2018-2024 (USD MILLION)
TABLE 194. EUROPE, MIDDLE EAST & AFRICA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY THERAPEUTIC, 2025-2030 (USD MILLION)
TABLE 195. EUROPE, MIDDLE EAST & AFRICA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
TABLE 196. EUROPE, MIDDLE EAST & AFRICA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
TABLE 197. EUROPE, MIDDLE EAST & AFRICA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY OPHTHALMOLOGY, 2018-2024 (USD MILLION)
TABLE 198. EUROPE, MIDDLE EAST & AFRICA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY OPHTHALMOLOGY, 2025-2030 (USD MILLION)
TABLE 199. EUROPE, MIDDLE EAST & AFRICA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 200. EUROPE, MIDDLE EAST & AFRICA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 201. EUROPE, MIDDLE EAST & AFRICA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PROTEIN EXPRESSION SYSTEM, 2018-2024 (USD MILLION)
TABLE 202. EUROPE, MIDDLE EAST & AFRICA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PROTEIN EXPRESSION SYSTEM, 2025-2030 (USD MILLION)
TABLE 203. EUROPE, MIDDLE EAST & AFRICA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 204. EUROPE, MIDDLE EAST & AFRICA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 205. EUROPE, MIDDLE EAST & AFRICA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 206. EUROPE, MIDDLE EAST & AFRICA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 207. EUROPE, MIDDLE EAST & AFRICA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PURITY GRADE, 2018-2024 (USD MILLION)
TABLE 208. EUROPE, MIDDLE EAST & AFRICA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PURITY GRADE, 2025-2030 (USD MILLION)
TABLE 209. EUROPE, MIDDLE EAST & AFRICA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 210. EUROPE, MIDDLE EAST & AFRICA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 211. UNITED KINGDOM HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 212. UNITED KINGDOM HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 213. UNITED KINGDOM HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY THERAPEUTIC, 2018-2024 (USD MILLION)
TABLE 214. UNITED KINGDOM HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY THERAPEUTIC, 2025-2030 (USD MILLION)
TABLE 215. UNITED KINGDOM HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
TABLE 216. UNITED KINGDOM HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
TABLE 217. UNITED KINGDOM HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY OPHTHALMOLOGY, 2018-2024 (USD MILLION)
TABLE 218. UNITED KINGDOM HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY OPHTHALMOLOGY, 2025-2030 (USD MILLION)
TABLE 219. UNITED KINGDOM HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 220. UNITED KINGDOM HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 221. UNITED KINGDOM HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PROTEIN EXPRESSION SYSTEM, 2018-2024 (USD MILLION)
TABLE 222. UNITED KINGDOM HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PROTEIN EXPRESSION SYSTEM, 2025-2030 (USD MILLION)
TABLE 223. UNITED KINGDOM HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 224. UNITED KINGDOM HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 225. UNITED KINGDOM HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 226. UNITED KINGDOM HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 227. UNITED KINGDOM HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PURITY GRADE, 2018-2024 (USD MILLION)
TABLE 228. UNITED KINGDOM HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PURITY GRADE, 2025-2030 (USD MILLION)
TABLE 229. GERMANY HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 230. GERMANY HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 231. GERMANY HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY THERAPEUTIC, 2018-2024 (USD MILLION)
TABLE 232. GERMANY HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY THERAPEUTIC, 2025-2030 (USD MILLION)
TABLE 233. GERMANY HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
TABLE 234. GERMANY HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
TABLE 235. GERMANY HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY OPHTHALMOLOGY, 2018-2024 (USD MILLION)
TABLE 236. GERMANY HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY OPHTHALMOLOGY, 2025-2030 (USD MILLION)
TABLE 237. GERMANY HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 238. GERMANY HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 239. GERMANY HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PROTEIN EXPRESSION SYSTEM, 2018-2024 (USD MILLION)
TABLE 240. GERMANY HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PROTEIN EXPRESSION SYSTEM, 2025-2030 (USD MILLION)
TABLE 241. GERMANY HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 242. GERMANY HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 243. GERMANY HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 244. GERMANY HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 245. GERMANY HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PURITY GRADE, 2018-2024 (USD MILLION)
TABLE 246. GERMANY HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PURITY GRADE, 2025-2030 (USD MILLION)
TABLE 247. FRANCE HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 248. FRANCE HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 249. FRANCE HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY THERAPEUTIC, 2018-2024 (USD MILLION)
TABLE 250. FRANCE HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY THERAPEUTIC, 2025-2030 (USD MILLION)
TABLE 251. FRANCE HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
TABLE 252. FRANCE HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
TABLE 253. FRANCE HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY OPHTHALMOLOGY, 2018-2024 (USD MILLION)
TABLE 254. FRANCE HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY OPHTHALMOLOGY, 2025-2030 (USD MILLION)
TABLE 255. FRANCE HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 256. FRANCE HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 257. FRANCE HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PROTEIN EXPRESSION SYSTEM, 2018-2024 (USD MILLION)
TABLE 258. FRANCE HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PROTEIN EXPRESSION SYSTEM, 2025-2030 (USD MILLION)
TABLE 259. FRANCE HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 260. FRANCE HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 261. FRANCE HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 262. FRANCE HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 263. FRANCE HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PURITY GRADE, 2018-2024 (USD MILLION)
TABLE 264. FRANCE HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PURITY GRADE, 2025-2030 (USD MILLION)
TABLE 265. RUSSIA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 266. RUSSIA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 267. RUSSIA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY THERAPEUTIC, 2018-2024 (USD MILLION)
TABLE 268. RUSSIA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY THERAPEUTIC, 2025-2030 (USD MILLION)
TABLE 269. RUSSIA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
TABLE 270. RUSSIA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
TABLE 271. RUSSIA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY OPHTHALMOLOGY, 2018-2024 (USD MILLION)
TABLE 272. RUSSIA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY OPHTHALMOLOGY, 2025-2030 (USD MILLION)
TABLE 273. RUSSIA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 274. RUSSIA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 275. RUSSIA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PROTEIN EXPRESSION SYSTEM, 2018-2024 (USD MILLION)
TABLE 276. RUSSIA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PROTEIN EXPRESSION SYSTEM, 2025-2030 (USD MILLION)
TABLE 277. RUSSIA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 278. RUSSIA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 279. RUSSIA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 280. RUSSIA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 281. RUSSIA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PURITY GRADE, 2018-2024 (USD MILLION)
TABLE 282. RUSSIA HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PURITY GRADE, 2025-2030 (USD MILLION)
TABLE 283. ITALY HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 284. ITALY HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 285. ITALY HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY THERAPEUTIC, 2018-2024 (USD MILLION)
TABLE 286. ITALY HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY THERAPEUTIC, 2025-2030 (USD MILLION)
TABLE 287. ITALY HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
TABLE 288. ITALY HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
TABLE 289. ITALY HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY OPHTHALMOLOGY, 2018-2024 (USD MILLION)
TABLE 290. ITALY HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY OPHTHALMOLOGY, 2025-2030 (USD MILLION)
TABLE 291. ITALY HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 292. ITALY HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 293. ITALY HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PROTEIN EXPRESSION SYSTEM, 2018-2024 (USD MILLION)
TABLE 294. ITALY HUMAN CILIARY NEUROTROPHIC FACTOR MARKET SIZE, BY PROTEIN EXPRESSION SYSTEM, 2025-2030 (USD MILLION)
TABLE 295. ITALY H
Samples
LOADING...
Companies Mentioned
The companies profiled in this Human Ciliary Neurotrophic Factor market report include:- Thermo Fisher Scientific Inc.
- Merck KGaA
- Bio-Techne Corporation
- Abcam plc
- Sino Biological Inc.
- GenScript Biotech Corporation
- RayBiotech, Inc.
- Proteintech Group, Inc.
- Creative Biolabs, Inc.
- Novus Biologicals LLC
